Donglan Liu
Guangzhou International Bio Island
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses.
Journal: Journal of virology
Published: August 31, 2026
Enhanced immunogenicity and dose-sparing efficacy of self-amplifying RNA vaccines against seasonal influenza across subtypes.
Journal: Emerging microbes & infections
Published: May 04, 2026
Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3CLpro Inhibitors.
Journal: ChemMedChem
Published: April 13, 2026
Adenovirus Nanoparticles Displaying RBD Induce a Protective Immune Response Against BA.5 in Mice.
Journal: International journal of nanomedicine
Published: February 24, 2025
Interferon-stimulated gene GALNT2 restricts respiratory virus infections.
Journal: Nature microbiology
Published: December 03, 2024
Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.
Journal: Nature immunology
Published: June 04, 2024
Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors.
Journal: International journal of biological macromolecules
Published: December 27, 2023
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein.
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein.
Journal: Acta pharmaceutica Sinica. B
Published: December 09, 2023
Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 25, 2023
Last Updated: 09/26/2026